The FDA just approved Viramune (nevirapine)
The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.
Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It inhibits the same enzyme as AZT...but it works in a different way.
Experts don't yet know exactly how to use this drug.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote